Publications by authors named "Wu-Song Xue"
A meta-analysis of safety and efficacy of regorafenib for refractory metastatic colorectal cancer.
Medicine (Baltimore)
October 2018
Background: Patients with metastatic colorectal cancer (mCRC) often suffer from progressive disease despite previous therapy. It has been a great challenge for those patients. In 2012, regorafenib was approved for mCRC.
View Article and Find Full Text PDF